These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 486733)

  • 21. [Undifferentiated carcinomas of the thyroid corpus. Apropos of 10 cases].
    Habib K; Auriol M; Sarfati E; de Roquancourt A; Wann AR; Brocheriou C; Chomette G
    Arch Anat Cytol Pathol; 1993; 41(3-4):129-39. PubMed ID: 8279854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
    Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
    J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of locally aggressive well-differentiated thyroid cancer.
    Martins AS; Melo GM; Valério JB; Langner E; Lage HT; Tincani AJ
    Int Surg; 2001; 86(4):213-9. PubMed ID: 12056464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy and survival in thyroid tumors].
    Rodari A
    Minerva Med; 1986 Nov; 77(44):2127-30. PubMed ID: 3785730
    [No Abstract]   [Full Text] [Related]  

  • 25. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
    Schlumberger M; Challeton C; De Vathaire F; Travagli JP; Gardet P; Lumbroso JD; Francese C; Fontaine F; Ricard M; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):598-605. PubMed ID: 8691248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracheal invasion by thyroid carcinoma.
    Lydiatt DD; Markin RS; Ogren FP
    Ear Nose Throat J; 1990 Mar; 69(3):145-9. PubMed ID: 2351077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic scoring systems in differentiated thyroid carcinoma: which is the best?
    Kingma G; van den Bergen HA; de Vries JE
    Neth J Surg; 1991 Jun; 43(3):63-6. PubMed ID: 1922882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term course in differentiated thyroid gland carcinoma].
    Rösler H; Birrer A; Lüscher D; Kinser J
    Schweiz Med Wochenschr; 1992 Nov; 122(48):1843-57. PubMed ID: 1462145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid.
    Podnos YD; Smith D; Wagman LD; Ellenhorn JD
    Surgery; 2005 Dec; 138(6):1072-6; discussion 1076-7. PubMed ID: 16360393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The biological classifications of malignant thyroid tumours (author's transl)].
    Kokoschka R; Roka R; Depisch D; Aiginger P; Weissel M; Kolbe H; Krisch K
    Wien Klin Wochenschr; 1979 Sep; 91(18):605-10. PubMed ID: 483824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the prognosis of patients with carcinoma of the thyroid.
    Ito J; Noguchi S; Murakami N; Noguchi A
    Surg Gynecol Obstet; 1980 Apr; 150(4):539-44. PubMed ID: 7361243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.
    Hamming JF; van de Velde CJ; Goslings BM; Fleuren GJ; Hermans J; Delemarre JF; van Slooten EA
    Surg Gynecol Obstet; 1989 Aug; 169(2):107-14. PubMed ID: 2667172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
    Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
    Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer.
    Shaha AR
    Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is age a prognostic factor in differentiated carcinoma of the thyroid gland? (author's transl)].
    Proye C; Maes B; Lagache G; Fossati P; Linquette M
    Nouv Presse Med; 1981 Dec; 10(45):3701-4. PubMed ID: 7322903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
    Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
    Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.